Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Yan Lin
Assoc Dir, Quant Research
Biostatistics
h-index
6952
Citations
48
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2008
2024
Research activity per year
Overview
Fingerprint
Network
Research output
(187)
Similar Profiles
(7)
Fingerprint
Dive into the research topics where Yan Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Neoplasms
100%
Survival
96%
Non-Small Cell Lung Carcinoma
80%
Breast Neoplasms
71%
Drug Therapy
51%
Multiple Myeloma
47%
Breast
46%
Therapeutics
40%
Liposarcoma
35%
Neoadjuvant Therapy
34%
Progression-Free Survival
33%
Inflammatory Breast Neoplasms
33%
Databases
32%
Lung Neoplasms
32%
Carcinoma, Intraductal, Noninfiltrating
32%
Squamous Cell Carcinoma of Head and Neck
30%
Nivolumab
30%
Sarcoma
30%
Recurrence
29%
Ipilimumab
29%
Prophylactic Mastectomy
29%
Mutation
28%
Radiotherapy
25%
Randomized Controlled Trials
21%
Enhancer of Zeste Homolog 2 Protein
20%
Adenocarcinoma of Lung
18%
Rheumatoid Arthritis
18%
Hematopoietic Stem Cell Transplantation
18%
Confidence Intervals
17%
Neoplasm Metastasis
17%
Docetaxel
16%
Malignant Mesothelioma
16%
Biomarkers
15%
Pamphlets
15%
Cisplatin
14%
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
14%
Osteosarcoma
14%
Mastectomy
14%
Platinum
14%
Neuroendocrine Tumors
13%
Lymph Node Ratio
13%
Induction Chemotherapy
13%
Systematic Reviews
13%
Hospitalists
13%
Lenalidomide
13%
ErbB Receptors
12%
Incidence
12%
Adjuvant Chemotherapy
12%
Genetic Testing
12%